“The current circumstance has exposed some structural weaknesses inside the EU’s medicines provide chain plus a large dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that offer chain difficulties be addressed in an EU pharmaceutical strategy anticipated to get introduced by the top wit